Back to All Events

Adult vaccination in practice with AREXVY & SHINGRIX

AREXVY (respiratory syncytial virus vaccine recombinant, adjuvanted)

SHINGRIX Recombinant Varicella Zoster Virus glycoprotein E antigen (AS01B adjuvanted vaccine)

For Australian Healthcare Professionals

Welcome!

Join us for an upcoming education webinar with Dr Rodney Pearce and Ms Philippa Holland to explore the burden of respiratory syncytical virus (RSV) and shingles in older adults.

Learning Objectives

RSV learning objectives

  • Identify older adults who are eligible for RSV vaccination

  • Educate patients on their individual risk of RSV disease and the efficacy and safety profile of AREXVY

  • Vaccinate with confidence by learning practical steps to administer AREXVY in everyday practice

Shingles learning objectives

  • Understand the risk and impact of shingles

  • Recognise the importance of vaccinating adults ≥50 years of age

  • Describe the clinical profile of SHINGRIX

  • Develop strategies for implementing SHINGRIX discussions within your practice

Register now
Previous
19 August

Parkinsons NSW: Parkinson’s care and treatment information seminar for general practitioners and health professionals
Next
25 August

Allied Health: Digital Lunch & Learn – National digital health platforms